Translating questions to estimands in randomized clinical trials with intercurrent events
From MaRDI portal
(Redirected from Publication:6628626)
Cites work
- ``Imagine a can opener -- the magic of principal stratum analysis
- A generalized theory of separable effects in competing event settings
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- Augmented Designs to Assess Immune Response in Vaccine Trials
- Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence
- Causal mediation of semicompeting risks
- Defining and estimating intervention effects for groups that will develop an auxiliary outcome
- Defining causal mediation with a longitudinal mediator and a survival outcome
- scientific article; zbMATH DE number 1493045 (Why is no real title available?)
- Identifying the consequences of dynamic treatment strategies: a decision-theoretic overview
- On Estimation of the Survivor Average Causal Effect in Observational Studies When Important Confounders Are Missing Due to Death
- Principal stratification -- a goal or a tool?
- Principal stratification -- uses and limitations
- Principal Stratification Analysis Using Principal Scores
- Principal stratification and attribution prohibition: good ideas taken too far
- Principal stratification in causal inference
- Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
Cited in
(8)- Multistate models as a framework for estimand specification in clinical trials of complex processes
- Single-world intervention graphs for defining, identifying, and communicating estimands in clinical trials
- An Example to Illustrate Randomized Trial Estimands and Estimators
- Assessing causal effects in the presence of treatment switching through principal stratification
- A positivity robust strategy to study effects of switching treatment
- Inference for cumulative incidences and treatment effects in randomized controlled trials with time-to-event outcomes under ICH E9 (R1)
- Hazards constitute key quantities for analyzing, interpreting and understanding time-to-event data
- Survivor average causal effects for continuous time: a principal stratification approach to causal inference with semicompeting risks
This page was built for publication: Translating questions to estimands in randomized clinical trials with intercurrent events
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628626)
